Form 4: Natera Executive Chairman Sells Shares Under Pre-Arranged Trading Plan
SEC Form 4 Filing
Natera's Executive Chairman, Matthew Rabinowitz, sold a significant number of shares on December 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Natera's Executive Chairman, Matthew Rabinowitz, sold a total of 419,890 shares of common stock on December 13, 2024.
- The sales were executed under a Rule 10b5-1 trading plan adopted on September 13, 2024.
- The shares were sold in multiple transactions at varying weighted average prices.
- The weighted average prices ranged from $164.6111 to $168.3547 per share.
- The total value of the shares sold is approximately $69,533,042.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction under a pre-arranged trading plan. It is neither particularly positive nor negative, but the market may react to the volume of shares sold.
Risks
- Large sales by company executives can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Executive share sales are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading. The market will likely assess the impact of this sale in the context of Natera's overall performance and outlook.
Comparison to Industry Standards
- Executive share sales are a common practice across publicly traded companies, especially in the biotech sector.
- The use of a Rule 10b5-1 trading plan is a standard method for executives to sell shares without raising concerns about insider trading.
- Comparable companies in the biotech space, such as Exact Sciences (EXAS) and Invitae (NVTA), also see similar transactions by their executives.
Stakeholder Impact
- Shareholders may react to the news of the Executive Chairman selling a significant number of shares.
- The sale could potentially impact the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 2024-09-13 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 2024-12-13 | Date of the share sales by the Executive Chairman. |
Keywords
Natera, NTRA, Executive Chairman, Matthew Rabinowitz, Share Sale, Rule 10b5-1, Trading Plan, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.